(Q33556411)

28 July 2017

Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash. (English)

1 reference

28 July 2017

1 reference

0 references

Bax DE

1

1 reference

PubMed ID

2868699

28 July 2017

Amos RS

series ordinal

2

1 reference

PubMed ID

2868699

28 July 2017

language of work or name

English

0 references

publication date

1 February 1986

1 reference

Annals of the Rheumatic Diseases

28 July 2017

1 reference

28 July 2017

45

1 reference

28 July 2017

2

1 reference

28 July 2017

139-140

1 reference

Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001835

Sulphasalazine desensitisation.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001835

Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001835

Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001835

31 October 2018

Identifiers

DOI

10.1136/ARD.45.2.139

1 reference

28 July 2017

1 reference

28 July 2017

1 reference

PubMed ID

2868699